Medication info
Esomeprazole Magnesium Trihydrate 40 mg Tablet

Esomeprazole Magnesium Trihydrate 40 mg Tablet

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›43.38mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Pink rectangular film-coated tablets
Packaging
28 tablets/box [7 tablets/Alu-Alu x 4]
Approval status
Active

MFDS item code 201901885 · Approved 2019.03.28 · Insurance code 670501500

Summary

Main use
Treatment of acid-related disorders (reflux and Zollinger-Ellison syndrome), ulcers and Helicobacter pylori infection, and gastrointestinal disorders caused by anti-inflammatory drugs
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Clinical trials lasting more than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses of more than 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. Renal impairment: No dose adjustment is necessary. Use with caution in patients with severe renal failure because experience in these patients is limited. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients: No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years or older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Adolescents aged 12 years or older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Adolescents aged 12 years or older: Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. Adolescents aged 12 years or older: In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Children under 12 years: There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (reflux and Zollinger-Ellison syndrome), ulcers and Helicobacter pylori infection, and gastrointestinal disorders caused by anti-inflammatory drugs

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • Zollinger-Ellison syndrome
  • rebleeding
View approved original text

This medicine is used for the treatment of gastroesophageal reflux disease and erosive reflux esophagitis, as well as for long-term maintenance therapy to prevent relapse in patients with esophagitis. It is effective for the treatment and prevention of relapse in patients with duodenal ulcers and peptic ulcers as part of an eradication therapy for Helicobacter pylori. Additionally, it is used for the relief of upper gastrointestinal symptoms occurring in patients taking non-steroidal anti-inflammatory drugs (NSAIDs), and for the treatment and prevention of gastric and duodenal ulcers. It is also utilized for the treatment of Zollinger-Ellison syndrome and for maintenance therapy after the prevention of rebleeding from gastric or duodenal ulcers. Overall, it is widely used to treat gastrointestinal diseases and related complications.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Clinical trials lasting more than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses of more than 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following initiation of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. Renal impairment: No dose adjustment is necessary. Use with caution in patients with severe renal failure because experience in these patients is limited. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly patients: No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years or older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Adolescents aged 12 years or older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Adolescents aged 12 years or older: Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. Adolescents aged 12 years or older: In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Children under 12 years: There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be used in certain patients. For example, it should be avoided in cases of allergy to this medication or its components, or if currently taking certain antibiotics or medications. When taking this medication, various side effects may occur, so caution is needed. Common side effects include headache, abdominal pain, and diarrhea, while rare but serious side effects may include blood abnormalities, hypersensitivity reactions, liver dysfunction, and skin rashes. Long-term use requires regular monitoring of health status, and particularly if taken for more than a year, blood tests to check for abnormalities such as magnesium levels are important. Since this medication suppresses stomach acid secretion, there may be a slightly increased risk of gastrointestinal bacterial infections. If diarrhea persists, consultation with a physician is necessary. Additionally, patients with osteoporosis or a high risk of fractures should exercise caution as long-term use of this medication may increase the risk of fractures. Due to many potential drug interactions, especially if taking anticoagulants, antiviral drugs, antibiotics, or anticonvulsants, consultation with a physician or pharmacist is absolutely essential. It is advisable to avoid using this medication during pregnancy or breastfeeding, and if necessary, to do so under professional guidance. In case of overdose, there is no specific antidote, so it is important to receive treatment according to symptoms, and the medication should be kept out of reach of children.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, xerostomia, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia with systemic symptom drug reaction, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, hyperhidrosis, Clostridium difficile-associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, substernal pain, facial swelling, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, tachycardia, flushing, hypertension, goiter, irritable bowel syndrome, constipation exacerbation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, arthritis exacerbation, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defect, dysmenorrhea, menstrual disorders, vaginitis, asthma exacerbation, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, altered olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is between 1 degree and 30 degrees Celsius at room temperature. Proper storage will maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Pink rectangular film-coated tablets

Package unit

28 tablets/box [7 tablets/Alu-Alu x 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.